이뮨온시아는 암 치료의 기준을 바꾸기 위한
면역항암제를 개발합니다.
- About Us
- 비전
비전
국내 최초의
면역항암제 상용화
면역항암제 상용화
Changing the Standard of cancer treatment
By Bringing Korea’s 1st immuno-oncology Drug
By Bringing Korea’s 1st immuno-oncology Drug
H.Q: 25, Tapsil-ro 35beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 17084, Republic of Korea
R&D Center: Suite 6F, Genexine ProGen Bio Innovation Park, 172, Magokjungang-ro, Gangseo-gu, Seoul, 07789, Replublic of Korea
R&D Center: Suite 6F, Genexine ProGen Bio Innovation Park, 172, Magokjungang-ro, Gangseo-gu, Seoul, 07789, Replublic of Korea
Copyright © ImmuneOncia. All Rights Reserved. DESIGNED BY DESIGNPIXEL